Andrew J. Schwab is Director & 10% Owner at Skye Bioscience, Inc. (SKYE). They have made 22 open-market trades across 12 companies since 2018, most recently 2026-09-23.
CIK 0001598549
4 open-market purchases totalling $30.0M since 2019, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELVN | 4,470,968 | $167.0M |
| FIXX | 4,834,484 | $81.3M |
| IDYA | 2,187,428 | $71.8M |
| RLYB | 2,378,969 | $39.2M |
| VOR | 1,766,634 | $31.9M |
| FLXN | 1,303,804 | $31.4M |
| ARVN | 3,888,216 | $27.1M |
| CAMP |
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 50% | 67% |
| Avg Move | +34.8% | +39.1% | -5.5% |
| Scored | 16 | 14 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SKYE | SELL | 2026-09-22 | 2026-09-24 | $1.62 | $240K | +5.9% | — | — |
| SKYE | SELL | 2026-09-16 | 2026-09-18 | $1.91 | $65K | -9.4% | — | — |
| CAMP | SELL | 2026-08-27 | 2026-08-31 | $4.04 | $1.6M | +11.8% | +4.5% | — |
| CAMP | SELL | 2026-08-24 | 2026-08-26 | $4.50 | $45 | +2.6% | -8.6% | — |
| CAMP | SELL | 2026-08-19 | 2026-08-21 | $4.59 | $880K | -11.0% | -2.6% | — |
| SKYE | SELL | 2026-08-18 | 2026-08-20 | $0.37 | $140K | +592.0% | +580.5% | — |
| SKYE | SELL | 2025-08-21 | 2025-08-22 | $3.46 | $1.6M | +10.3% | +14.4% | -63.2% |
| TRDA | SELL | 2025-06-27 | 2025-07-01 | $6.93 | $1.6M | -4.4% | -17.3% | -17.9% |
| CAMP | BUY | 2024-10-15 | 2024-10-15 | $11.00 | $10.0M | +0.4% | -13.8% | -64.6% |
| SKYE | SELL | 2024-09-11 | 2024-09-13 | $6.57 | $3.5M | -34.9% | -31.6% | -44.0% |
| ELVN | SELL | 2023-08-24 | 2023-08-28 | $16.00 | $7.0M | +1.9% | -15.0% | -32.6% |
| RLYB | SELL | 2023-03-07 | 2023-03-09 | $8.20 | $1.6M | -10.2% | -8.6% | +54.6% |
| PEAR | SELL | 2022-08-16 | 2022-08-18 | $1.65 | $1.3M | +11.0% | +7.5% | +31.5% |
| VOR | SELL | 2021-11-16 | 2021-11-18 | $15.30 | $6.5M | -18.6% | -12.1% | -32.7% |
| TRDA | BUY | 2021-11-02 | 2021-11-04 | $20.00 | $5.0M | +35.0% | -12.1% | -62.8% |
| FIXX | SELL | 2020-12-14 | 2020-12-16 | $12.25 | $12.3M | +1.0% | +13.1% | -12.2% |
| CABA | SELL | 2020-12-10 | 2020-12-14 | $14.75 | $4.4M | -15.7% | -6.0% | -19.5% |
| IDYA | SELL | 2020-11-11 | 2020-11-13 | $13.66 | $21.9M | -1.5% | +2.6% | +42.2% |
| SCPH | BUY | 2020-05-26 | 2020-05-28 | $8.65 | $10.0M | -7.4% | -10.5% | -4.2% |
| CABA | BUY | 2019-10-29 | 2019-10-31 | $11.00 | $5.0M | +12.0% | +40.0% | +77.6% |
| ARVN | SELL | 2019-06-27 | 2019-07-01 | $21.87 | $35.4M | +10.0% | +17.4% | -5.1% |
| FIXX | SELL | 2018-11-23 | 2018-11-27 | $20.04 | $1.2M | +30.1% | +5.2% | +33.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| 2,033,270 |
| $6.5M |
| TRDA | 1,106,670 | $4.8M |
| SCPH | 578,034 | $3.3M |
| CABA | 417,629 | $591K |
| PEAR | 14,478,491 | $423K |
| SKYE | 4,528 | $7K |
| FVAM | 365,126 | — |
| Total | $465.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-24 close. 1 holding could not be priced and is excluded from the total.